Grow Pharma has achieved another milestone in the supply of cannabis-based medicinal products (CBMPs) to patients by trialling an extraction of a CBMP in a UK licensed facility. Read the full press release below:https://pressat.co.uk/releases/uk-medicinal-cannabis-company-grow-pharma-to-produce-cannabis-based-medicinal-products-for-patients-facing-possible-disruption-in-supply-36899a3664bf74e746ec6c8b9098c02c/
Check out what we have to say.
Medical cannabis biopharma leader Grow launches GBP 6 million Series C fundraise to scale-up existing UK operations and accelerate expansion across Europe. Grow seeks to accelerate towards its goal of being the world’s leading supplier
Grow Pharma and our partner IPS Pharma have just dispensed the first-ever medical cannabis prescription to a patient in Guernsey. Great to see that people in Guernsey can now access a broad range of prescribed
Our team at Grow Pharma is very proud to lead a national coalition for public information on cannabis medicines in the UK through a multi-media, multi-stakeholder public education campaign called Open Cannabis. We’ve brought together a
Australian pharmaceutical company Althea Group Holdings Limited (ASX:AGH) (‘Althea’ or ‘the Company’) is pleased to announce it has executed a Medicinal Cannabis Supply Agreement (‘agreement‘) with UK-based Grow Pharma to import, sell and distribute Althea products
This is a major step for Grow Biotech in its mission to enable access to cannabis medicines to patients who need them. On Monday 2nd March, the UK government announced changes to the rules on